Funds · AQST

Who owns AQST?

Institutional ownership of Aquestive Therapeutics Inc. from Form 13F, Q2 2026

185 institutional managers reported holding Aquestive Therapeutics Inc. (AQST) in Form 13F filings for Q2 2026, with 72,032,806 shares worth $300M. The largest reported holder was Bratton Capital Management, L.P. Managers that filed both quarters added a net 144,253 shares (+0.2%). 23 opened new positions and 18 sold out.

Funds holding
185
Value held
$300M
New / sold out
23 / 18
Net shares, same filers
+0.2%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of AQST

FundValueShare of 13F holdingsSharesMove
Bratton Capital Management, L.P.$40.8M13.6%9,810,958Unchanged
BlackRock, Inc.$33.6M11.2%8,069,373Added
RTW Investments, LP$30.9M10.3%7,426,471Unchanged
Vanguard Capital Management LLC$19.1M6.4%4,584,533Added
Federated Hermes, Inc.$12.9M4.3%3,112,561Added
State Street Corp$12.2M4.1%2,928,020Added
Geode Capital Management, LLC$10.9M3.6%2,622,888Added
Samsara Biocapital, LLC$10.4M3.5%2,500,000Unchanged
Bank of America Corp$6.9M2.3%1,668,423Trimmed
Sio Capital Management, LLC$6.2M2.1%1,486,175Trimmed
Propel Bio Management, LLC$6.0M2.0%1,442,397Added
Wasatch Advisors LP$5.8M1.9%1,385,843Added
Two Sigma Investments, LP$5.3M1.8%1,281,227Added
Nuveen, LLC$5.1M1.7%1,215,225Added
Janney Montgomery Scott LLC$4.6M1.5%1,106,160Added
Wells Fargo & Company$4.5M1.5%1,089,037Added
Commonwealth Equity Services, LLC$4.4M1.5%1,046,175Trimmed
Barclays PLC$4.1M1.4%996,665Added
Blue Owl Capital Holdings LP$3.9M1.3%942,932Trimmed
Northern Trust Corp$3.5M1.2%831,151Added
BNP Paribas Financial Markets$3.3M1.1%794,688Trimmed
Balyasny Asset Management L.P.$3.1M1.0%744,536Trimmed
Vanguard Portfolio Management LLC$3.1M1.0%734,245Added
Morgan Stanley$2.7M0.9%658,617Trimmed
Vanguard Fiduciary Trust Co$2.7M0.9%651,211Added

Share of 13F holdings is each fund's shares as a share of the 72,032,806 AQST shares all 13F filers reported, not of shares outstanding.

Biggest buyers in Q2 2026

  1. Nuveen, LLC Added+$4.0M
  2. Propel Bio Management, LLC Added+$3.0M
  3. BlackRock, Inc. Added+$2.3M
  4. Wasatch Advisors LP Added+$2.1M
  5. Renaissance Technologies LLC New+$1.7M
  6. State Street Corp Added+$1.6M
  7. Man Group plc New+$1.5M
  8. HRT Financial LP New+$1.4M
  9. DAFNA Capital Management LLC Added+$1.2M
  10. Marshall Wace, LLP Added+$1.1M

Biggest sellers in Q2 2026

  1. Balyasny Asset Management L.P. Trimmed-$9.0M
  2. Morgan Stanley Trimmed-$3.9M
  3. Bank of America Corp Trimmed-$3.1M
  4. Jane Street Group, LLC Trimmed-$2.5M
  5. Sio Capital Management, LLC Trimmed-$1.8M
  6. Blue Owl Capital Holdings LP Trimmed-$1.7M
  7. Diametric Capital, LP Sold out-$1.4M
  8. Walleye Capital LLC Trimmed-$1.3M
  9. Point72 Asset Management, L.P. Sold out-$1.2M
  10. Susquehanna International Group, LLP Trimmed-$870K

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $31.6M and sold $31.0M; 68 added and 44 trimmed.

Questions about AQST ownership

Who owns AQST stock?
185 institutional investment managers reported AQST positions in their Form 13F filings for Q2 2026, holding 72,032,806 shares worth $300M in total. Bratton Capital Management, L.P. reported the largest position.
Are funds buying or selling AQST?
In Q2 2026, 23 managers opened new AQST positions, 68 added, 44 trimmed and 18 sold out. Managers that filed in both quarters added a net 144,253 shares.
How current is this AQST institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AQST by CUSIP. Options are left out. AQST news and filings · AQST insider trades · Top funds